Live Breaking News & Updates on Helsinn Group|Page 5

Stay updated with breaking news from Helsinn group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Helsinn Healthcare S.A.: Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia

Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia Lugano, Switzerland, November 29, 2022 - Helsinn Group ("Helsinn"), a fully integrated global ....

United States , United Kingdom , Alex Molassiotis , Netupitant Palonosetron , Marika Chr , Paola Bonvicini , Lee Schwartzberg , George Dranitsaris , Alessandro Alonzi , Kostenloser Wertpapierhandel , Silvia Olivari Tilola , Ericj Roeland , Carole Terrasanta , Silvia Sebastiani , Helsinn Group , Sasia Congress , Helsinn Birex Pharmaceuticals Ltd , Group Head Of Communication , European Society For Medical Oncology , University Of Derby , National Comprehensive Cancer Network , Helsinn Group Head Of Medical Affairs , European Society , Medical Oncology , Fixed Combination , Matti Aapro ,

Helsinn Healthcare S.A.: Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy

Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy Lugano, Switzerland, October 18, 2022 - Helsinn Group ("Helsinn"), a fully integrated, global ....

United States , Alessandro Alonzi , Pablol Ortiz Romero , Kostenloser Wertpapierhandel , Paola Bonvicini , Stefano Frizzarin , Claudio Giuliano , Silvia Sebastiani , Helsinn Therapeutics Us Inc , European Commission , Helsinn Group , Helsinn Birex Pharmaceuticals Ltd , Group Head Of Communication , Group Head Of Medical Affairs , Mycosis Fungoides Cutaneoust Cell Lymphoma , Vitro Release , Permeation Testing , Virginia Stimamiglio , Group Head , Medical Affairs , Helsinn Therapeutics , Prescribing Information , Medication Guide , Helsinn Birex Pharmaceuticals , Media Contact ,

FDA approves Taiho drug for rare bile duct cancer with certain genetic signature

Taiho Oncology’s cancer drug Lytgobi is the third FDA-approved therapy for bile duct cancer driven by FGFR2 genetic alterations. The accelerated approval for Taiho’s drug follows regulatory nods for products from Incyte and QED Therapeutics that address the same genetic signature. ....

United States , Hong Kong , Bio Pharma , Incyte Pemazyre , Helsinn Group , Otsuka Holdings , American Cancer Society , Taiho Oncology , American Cancer , Switzerland Based Helsinn Group , New Jersey Based Taiho Oncology , Taiho Pharmaceutical , Tokyo Based Otsuka Holdings , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It ,

Helsinn Healthcare S.A.: Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting

Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting Data on chlormethine in both clinical trials and real-world settings will be ....

United States , Thomas Jefferson University , Twitterand Linkedin , Paola Bonvicini , Chalid Assaf , Juliaj Scarisbrick , Christiane Querfeld , Daniel Joffe , Laura Gleason , Kostenloser Wertpapierhandel , Pablo Ortiz Romero , Emmanuella Guenova , Silvia Sebastiani , Marta Scandurra , Marco Turini , Klinikum Krefeld , European Commission , Helsinn Group , European Organisation For Research , Helsinn Birex Pharmaceuticals Ltd , Group Head Of Communication , Lausanne University Hospital , Head Of Dermatology At University Hospital , Group Head Of Medical Affairs , Department Of Dermatology , European Organisation ,

Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting

Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting Data on chlo. ....

United States , Thomas Jefferson University , Paola Bonvicini , Chalid Assaf , Juliaj Scarisbrick , Christiane Querfeld , Daniel Joffe , Laura Gleason , Pablo Ortiz Romero , Emmanuella Guenova , Silvia Sebastiani , Marta Scandurra , Marco Turini , Klinikum Krefeld , Helsinn Therapeutics Us Inc , European Commission , Helsinn Group , European Organisation For Research , Helsinn Birex Pharmaceuticals Ltd , Group Head Of Communication , Head Of Dermatology At University Hospital , Lausanne University Hospital , Group Head Of Medical Affairs , Department Of Dermatology , European Organisation , Cancer Cutaneous Lymphoma Tumors Group ,